Kliger Alan S
Department of Medicine, Yale School of Medicine, Yale New Haven Health System, New Haven, Connecticut
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):363-8. doi: 10.2215/CJN.06010615. Epub 2015 Aug 27.
Recent federal legislation establishes a merit-based incentive payment system for physicians, with a scorecard for each professional. The Centers for Medicare and Medicaid Services evaluate quality of care with clinical performance measures and have used these metrics for public reporting and payment to dialysis facilities. Similar metrics may be used for the future merit-based incentive payment system. In nephrology, most clinical performance measures measure processes and intermediate outcomes of care. These metrics were developed from population studies of best practice and do not identify opportunities for individualizing care on the basis of patient characteristics and individual goals of treatment. The In-Center Hemodialysis (ICH) Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey examines patients' perception of care and has entered the arena to evaluate quality of care. A balanced scorecard of quality performance should include three elements: population-based best clinical practice, patient perceptions, and individually crafted patient goals of care.
近期的联邦立法为医生建立了基于绩效的激励支付系统,为每个专业制定了记分卡。医疗保险和医疗补助服务中心通过临床绩效指标评估医疗质量,并已将这些指标用于向透析机构进行公开报告和支付。类似的指标可能会用于未来基于绩效的激励支付系统。在肾脏病学领域,大多数临床绩效指标衡量的是医疗过程和中间结果。这些指标是根据最佳实践的人群研究制定的,并未根据患者特征和个体治疗目标确定个性化医疗的机会。中心血液透析(ICH)医疗服务提供者和系统消费者评估(CAHPS)调查考察了患者对医疗的看法,并已进入评估医疗质量的领域。质量绩效平衡记分卡应包括三个要素:基于人群的最佳临床实践、患者看法以及精心制定的个体患者护理目标。